Arkolith/Insider Trading/CTMX/Form 4

McCarthy Sean A.

CEO, DirectorCytomX Therapeutics, Inc. (CTMX) · full profile →Form 4 · filed Feb 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2025Grant(A)195K—$01.0M
Feb 4, 2025Grant(A)180K—$0838K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2025Grant(A)800K—$0800K
Feb 4, 2025Grant(A)390K—$0390K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML